Literature DB >> 3300384

A classification of cardiac allograft rejection. A modification of the classification by Billingham.

J Kemnitz, T Cohnert, H J Schäfers, M Helmke, T Wahlers, G Herrmann, R M Schmidt, A Haverich.   

Abstract

We herein propose a classification of rejection in cardiac allografts based on the original Stanford work. Our modified classification, as a work hypothesis, defines the following grades: mild acute rejection (A-1), corresponding to Billingham's "mild rejection"; mild acute rejection with probable conversion to moderate rejection (A-2); moderate acute rejection (A-3), comparable to Billingham's "moderate rejection"; and severe acute rejection (A-4), morphologically identical with the respective grade in the Billingham classification. The resolution of rejection has been classified into two grades--early (A-5a) and late (A-5b) resolution--according to the development of granulation tissues. We also grade the degree of vasculopathy (B-1, B-2) and chronic rejection (C), which is characterized by aggressive fibrosis and persistent vasculopathy. Mild rejection with possible conversion to moderate rejection is defined by an increasing quantity of retrogressive changes in myocytes. Changes not related to transplantation are characterized in our classification by descriptive diagnosis. The proposed classification was validated by 1 year of clinical experience and by the evaluation of possible prognostic aspects of the classification.

Entities:  

Mesh:

Year:  1987        PMID: 3300384     DOI: 10.1097/00000478-198707000-00002

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

Review 1.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

2.  Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption.

Authors:  A J Demetris; N Murase; Q Ye; F H Galvao; C Richert; R Saad; S Pham; R J Duquesnoy; A Zeevi; J J Fung; T E Starzl
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

3.  Detection of diastolic dysfunction: acoustic quantification (AQ) in comparison to Doppler echocardiography.

Authors:  B Hausmann; S Muurling; C Stauch; A Haverich; S Hirt; R Simon
Journal:  Int J Card Imaging       Date:  1997-08

Review 4.  Heart transplantation: cellular and humoral immunity.

Authors:  M L Rose; M H Yacoub
Journal:  Springer Semin Immunopathol       Date:  1989

5.  Enhanced lymphocyte longevity and absence of proliferation and lymphocyte apoptosis in Quilty effects of human heart allografts.

Authors:  C Dong; G L Winters; J E Wilson; B M McManus
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

Review 6.  Endomyocardial biopsy in the evaluation of conditions leading to cardiac transplantation and in the evaluation of cardiac allograft rejection.

Authors:  H A McAllister
Journal:  Tex Heart Inst J       Date:  1995

7.  Differential infiltration by CD45RO and CD45RA subsets of T cells associated with human heart allograft rejection.

Authors:  S Ibrahim; D V Dawson; P Van Trigt; F Sanfilippo
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

8.  Endothelial-cell injury in cutaneous acute graft-versus-host disease.

Authors:  J S Dumler; W E Beschorner; E R Farmer; K A Di Gennaro; R Saral; G W Santos
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

9.  201Tl myocardial perfusion in the management of the transplanted heart.

Authors:  J Richter; J Herreros; A Serena; M Domper; J C Ramirez; A Gómez; R Arcas
Journal:  Eur J Nucl Med       Date:  1990

10.  Cardiomyopathy development protection after myocardial infarction in rats: Successful competition for major dihydropyridines' common metabolite against captopril.

Authors:  Katarzyna A Mitręga; Adrianna M Spałek; Jerzy Nożyński; Maurycy Porc; Magdalena Stankiewicz; Tadeusz F Krzemiński
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.